-
公开(公告)号:US11878079B2
公开(公告)日:2024-01-23
申请号:US18145463
申请日:2022-12-22
申请人: Capsugel Belgium NV
CPC分类号: A61K9/4816 , A61K47/36
摘要: The instant disclosure provides a capsule composition comprising pullulan, a setting system and a surfactant system that is a sucroglyceride or a sugar fatty acid ester, and methods for making such capsules.
-
公开(公告)号:US20170095426A1
公开(公告)日:2017-04-06
申请号:US15313074
申请日:2015-05-14
申请人: Capsugel Belgium NV
IPC分类号: A61K9/48 , A61K9/00 , A61K35/612
CPC分类号: A61K9/4825 , A61K9/0053 , A61K9/4866 , A61K9/4875 , A61K35/612
摘要: A novel gelatin comprising dosage form article for oral administration and for containing therein a fill composition, the fill composition comprising one or more active materials capable of reacting with gelatin, and optionally one or more excipient materials, wherein the dosage form is made of a gelatin material and one or more plasticizers, the gelatin material having a mean molecular weight of less than about 130,000 g/mol and a low microgel content, wherein the fraction of microgel is of less than about 10% of the total number of gelatin chains of said gelatin material.
-
公开(公告)号:US20230131084A1
公开(公告)日:2023-04-27
申请号:US18145463
申请日:2022-12-22
申请人: Capsugel Belgium NV
摘要: The instant disclosure provides a capsule composition comprising pullulan, a setting system and a surfactant system that is a sucroglyceride or a sugar fatty acid ester, and methods for making such capsules.
-
公开(公告)号:US11576870B2
公开(公告)日:2023-02-14
申请号:US16604540
申请日:2018-04-10
申请人: Capsugel Belgium NV
摘要: The instant disclosure provides a capsule composition comprising pullulan, a setting system and a surfactant system that is a sucroglyceride or a sugar fatty acid ester, and methods for making such capsules.
-
公开(公告)号:US10016369B2
公开(公告)日:2018-07-10
申请号:US15313074
申请日:2015-05-14
申请人: Capsugel Belgium NV
IPC分类号: A61K9/48 , A61K35/612 , A61K9/00
CPC分类号: A61K9/4825 , A61K9/0053 , A61K9/4866 , A61K9/4875 , A61K35/612
摘要: A novel gelatin comprising dosage form article for oral administration and for containing therein a fill composition, the fill composition comprising one or more active materials capable of reacting with gelatin, and optionally one or more excipient materials, wherein the dosage form is made of a gelatin material and one or more plasticizers, the gelatin material having a mean molecular weight of less than about 130,000 g/mol and a low microgel content, wherein the fraction of microgel is of less than about 10% of the total number of gelatin chains of the gelatin material.
-
-
-
-